Biogen Introduces Innovative ALS Therapy with Qalsody


Biogen Inc. recently released Qalsody, a new treatment for Amyotrophic Lateral Sclerosis (ALS). This drug is the first of its kind to target the root cause of the disease instead of just managing symptoms. In clinical trials, patients taking Qalsody showed significant improvement in their motor function and better overall quality of life. Qalsody is a groundbreaking advancement for ALS treatments, offering hope to those suffering from this debilitating disease.